Para IV Winners and Losers - July 2018
This month’s Para IV developments suggest that there is likely to be benefit to Par Pharma, Dr. Reddy'S Laboratories (DRRD IN) & Amneal...
470 Views
Entero Healthcare: New Titan of Pharma Distribution
Entero Healthcare's dual-value model targets high-margin MedTech segment, aiming for INR 1,000 crore revenue with positive cash flow expected in...
389 Views
Corona Remedies IPO Review: Rolling up Growth
CRL focuses on chronic therapies for Women's healthcare and cardio-diabetics, with a diverse portfolio of 550+ products. It follows a roll-up...
397 Views
Corona Remedies IPO: Well-Positioned for Multi-Year Profitable Growth
Corona Remedies IPO will open for subscription on December 8 and close on December 10. The IPO price band has been set at INR1,008–1,062 per share....
539 Views
India: Potential Free Float Changes & Passive Flows in November
Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices in November. Passive trackers will need to...
738 Views